Patterns and predictors of anxiety and depression symptom trajectories in patients diagnosed with primary brain tumors

Mausbach BT, Decastro G, Schwab RB, Tiamson-Kassab M, Irwin SA (2020) Healthcare use and costs in adult cancer patients with anxiety and depression. Depress Anxiety 37(9):908–915. https://doi.org/10.1002/da.23059

Article  PubMed  PubMed Central  Google Scholar 

Mausbach BT, Irwin SA (2017) Depression and healthcare service utilization in patients with cancer. Psychooncology 26(8):1133–1139. https://doi.org/10.1002/pon.4133

Article  PubMed  Google Scholar 

Pinquart M, Duberstein PR (2010) Depression and cancer mortality: a meta-analysis. Psychol Med 40(11):1797–1810. https://doi.org/10.1017/S0033291709992285

Article  CAS  PubMed  PubMed Central  Google Scholar 

Spiegel D, Giese-Davis J (2003) Depression and cancer: mechanisms and disease progression. BiolPsychiatry. 54(3):269–282

Google Scholar 

Satin JR, Linden W, Phillips MJ (2009) Depression as a predictor of disease progression and mortality in cancer patients. Cancer 115(22):5349–5361. https://doi.org/10.1002/cncr.24561

Article  CAS  PubMed  Google Scholar 

Antoni MH, Lutgendorf SK, Cole SW et al (2006) The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat. Rev. Cancer 6(3):240–248

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arnold SD, Forman LM, Brigidi BD et al (2008) Evaluation and characterization of generalized anxiety and depression in patients with primary brain tumors. Neuro Oncol 10(2):171–181. https://doi.org/10.1215/15228517-2007-057

Article  PubMed  PubMed Central  Google Scholar 

Chambers SK, Grassi L, Hyde MK, Holland J, Dunn J (2015) Integrating psychosocial care into neuro-oncology: challenges and strategies. Front Oncol 5:41. https://doi.org/10.3389/fonc.2015.00041

Article  PubMed  PubMed Central  Google Scholar 

Gibson AW, Graber JJ (2021) Distinguishing and treating depression, anxiety, adjustment, and post-traumatic stress disorders in brain tumor patients. Ann Palliat Med 10(1):875–892. https://doi.org/10.21037/apm-20-509

Article  PubMed  Google Scholar 

Pelletier G, Verhoef MJ, Khatri N, Hagen N (2002) Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neurooncol 57(1):41–49. https://doi.org/10.1023/a:1015728825642

Article  PubMed  Google Scholar 

Rooney AG, Carson A, Grant R (2011) Depression in cerebral glioma patients: a systematic review of observational studies. J Natl Cancer Inst 103(1):61–76. https://doi.org/10.1093/jnci/djq458

Article  PubMed  Google Scholar 

Rooney AG, McNamara S, Mackinnon M et al (2011) Frequency, clinical associations, and longitudinal course of major depressive disorder in adults with cerebral glioma. J Clin Oncol 29(32):4307–4312. https://doi.org/10.1200/JCO.2011.34.8466

Article  PubMed  Google Scholar 

van der Meer PB, Dirven L, Hertler C et al (2023) Depression and anxiety in glioma patients. Neuro-Oncol Pract. https://doi.org/10.1093/nop/npad019

Article  Google Scholar 

Mainio A, Hakko H, Niemela A, Koivukangas J, Rasanen P (2005) Depression and functional outcome in patients with brain tumors: a population-based 1-year follow-up study. J Neurosurg 103(5):841–847. https://doi.org/10.3171/jns.2005.103.5.0841

Article  PubMed  Google Scholar 

Rooney AG, Brown PD, Reijneveld JC, Grant R (2014) Depression in glioma: a primer for clinicians and researchers. J Neurol Neurosurg Psychiatry 85(2):230–235. https://doi.org/10.1136/jnnp-2013-306497

Article  PubMed  Google Scholar 

D’Angelo C, Mirijello A, Leggio L et al (2008) State and trait anxiety and depression in patients with primary brain tumors before and after surgery: 1-year longitudinal study. J Neurosurg 108(2):281–286. https://doi.org/10.3171/JNS/2008/108/2/0281

Article  PubMed  Google Scholar 

Piil K, Jakobsen J, Christensen KB, Juhler M, Jarden M (2015) Health-related quality of life in patients with high-grade gliomas: a quantitative longitudinal study. J Neurooncol 124(2):185–195. https://doi.org/10.1007/s11060-015-1821-2

Article  CAS  PubMed  Google Scholar 

Pringle AM, Taylor R, Whittle IR (1999) Anxiety and depression in patients with an intracranial neoplasm before and after tumour surgery. Br J Neurosurg 13(1):46–51. https://doi.org/10.1080/02688699944177

Article  CAS  PubMed  Google Scholar 

Litofsky NS, Farace E, Anderson F Jr et al (2004) Depression in patients with high-grade glioma: results of the glioma outcomes project. Neurosurgery 54(2):358–66. https://doi.org/10.1227/01.neu.0000103450.94724.a2

Article  PubMed  Google Scholar 

Tibbs MD, Huynh-Le MP, Reyes A et al (2020) Longitudinal analysis of depression and anxiety symptoms as independent predictors of neurocognitive function in primary brain tumor patients. Int J Radiat Oncol Biol Phys 108(5):1229–1239. https://doi.org/10.1016/j.ijrobp.2020.07.002

Article  PubMed  PubMed Central  Google Scholar 

Cella D, Riley W, Stone A et al (2010) The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. J Clin Epidemiol 63(11):1179–1194. https://doi.org/10.1016/j.jclinepi.2010.04.011

Article  PubMed  PubMed Central  Google Scholar 

Terwee CB, Peipert JD, Chapman R et al (2021) Minimal important change (MIC): a conceptual clarification and systematic review of MIC estimates of PROMIS measures. Qual Life Res 30(10):2729–2754. https://doi.org/10.1007/s11136-021-02925-y

Article  PubMed  PubMed Central  Google Scholar 

Yost KJ, Eton DT, Garcia SF, Cella D (2011) Minimally important differences were estimated for six patient-reported outcomes measurement information system-cancer scales in advanced-stage cancer patients. J Clin Epidemiol 64(5):507–516. https://doi.org/10.1016/j.jclinepi.2010.11.018

Article  PubMed  PubMed Central  Google Scholar 

Thavarajah N, Bedard G, Zhang L et al (2014) Psychometric validation of the functional assessment of cancer therapy–brain (FACT-Br) for assessing quality of life in patients with brain metastases. Support Care Cancer 22(4):1017–1028. https://doi.org/10.1007/s00520-013-2060-8

Article  PubMed  Google Scholar 

Weitzner MA, Meyers CA, Gelke CK, Byrne KS, Cella DF, Levin VA (1995) The functional assessment of cancer therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer 75(5):1151–1161

Article  CAS  PubMed  Google Scholar 

Little RJA (1998) A test of missing completely at random for multivariate data with missing values. J Am Stat Assoc 83(404):1198–1202. https://doi.org/10.1080/01621459.1988.10478722

Article  Google Scholar 

Multiple regression: Testing and interpreting interactions. Thousand Oaks, CA, US.

McNeish D, Matta T (2018) Differentiating between mixed-effects and latent-curve approaches to growth modeling. Behav Res Methods 50(4):1398–1414. https://doi.org/10.3758/s13428-017-0976-5

Article  PubMed  Google Scholar 

Lai JS, Beaumont JL, Kupst MJ et al (2020) Symptom burden trajectories experienced by patients with brain tumors. Cancer 126(14):3341–3351. https://doi.org/10.1002/cncr.32879

Article  PubMed  Google Scholar 

Liu F, Huang J, Zhang L et al (2018) Screening for distress in patients with primary brain tumor using distress thermometer: a systematic review and meta-analysis. BMC Cancer 18(1):124. https://doi.org/10.1186/s12885-018-3990-9

Article  PubMed  PubMed Central  Google Scholar 

Baker PD, Bambrough J, Fox JRE, Kyle SD (2016) Health-related quality of life and psychological functioning in patients with primary malignant brain tumors: a systematic review of clinical, demographic and mental health factors. Neurooncol Pract 3(4):211–221. https://doi.org/10.1093/nop/npv042

Article  PubMed  Google Scholar 

McDonald PG, Antoni MH, Lutgendorf SK et al (2005) A biobehavioral perspective of tumor biology. Discov Med 5(30):520–526

PubMed  PubMed Central  Google Scholar 

Anderson J, Burney S, Brooker JE et al (2014) Anxiety in the management of localised prostate cancer by active surveillance. BJU Int 114(Suppl 1):55–61. https://doi.org/10.1111/bju.12765

Article  PubMed  Google Scholar 

Wagner LI, Spiegel D, Pearman T (2013) Using the science of psychosocial care to implement the new American college of surgeons commission on cancer distress screening standard. J Natl Compr Canc Netw 11(2):214–221. https://doi.org/10.6004/jnccn.2013.0028

Article  PubMed  Google Scholar 

Institute of Medicine Committee on Psychosocial Services to Cancer Patients/Families in a Community S. The National Academies Collection: Reports funded by National Institutes of Health. In: Adler NE, Page AEK, eds. Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs. National Academies Press (US) Copyright © 2008, National Academy of Sciences.; 2008.

(1999) NCCN practice guidelines for the management of psychosocial distress. National Comprehensive Cancer Network. Oncology (Williston Park). 13(5a):113–47

Beevers Z, Hussain S, Boele FW, Rooney AG (2020) Pharmacological treatment of depression in people with a primary brain tumour. Cochrane Database Syst Rev 7(7):32. https://doi.org/10.1002/14651858.CD006932.pub4

Article  Google Scholar 

Kangas M (2015) Psychotherapy interventions for managing anxiety and depressive symptoms in adult brain tumor patients: a scoping review. Front Oncol 5:116. https://doi.org/10.3389/fonc.2015.00116

Article  PubMed  PubMed Central  Google Scholar 

留言 (0)

沒有登入
gif